Why Stakk Landing an FBI Signature Verification Contract Is a Watershed Moment for the Company

Sonal Goyal

29 September 2026 05:32 PM AEST

Why Stakk Landing an FBI Signature Verification Contract Is a Watershed Moment for the Company

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Stakk Limited (ASX:SKK), the document and signature intelligence company, has secured one of the most significant contract wins in its history: the engagement of its Subsidiary ParaScript to deliver signature verification capabilities for use by the United States Federal Bureau of Investigation. With Phase 1 of the deployment already live and Phase 2 underway, this contract establishes a live law enforcement use case for ParaScript's technology that few companies can claim.

About the Company

Stakk Limited is an ASX-listed technology company specialising in document and signature intelligence — the AI-powered assessment of physical and digital signatures and documents where authenticity or potential Fraud is in question. The company expanded its capabilities significantly through the Acquisition of ParaScript, a US-based provider of signature verification technology with deep expertise in government and financial services applications. Stakk's technology supports use cases across financial services, healthcare, insurance, telecommunications, and government, with Demand driven by increasing AI-powered fraud sophistication.

Recent Development

In an ASX announcement dated 29 September 2026, Stakk disclosed that ParaScript, working with its strategic partner in the US government sector, has been engaged to deliver signature verification capabilities for use by the FBI. Phase 1 of the deployment is fully live, and Phase 2 — adding capabilities to locate and prepare reference signatures for the verification process — is underway. The engagement is subject to an agreement running to December 2027, with auto-renewal for subsequent 12-month terms unless terminated. It is expected to contribute meaningfully to Stakk's FY2027 Revenue target, which is now expected to surpass $55 million. The contract's commercial terms and operational details are confidential. The engagement establishes a live law enforcement deployment that Stakk intends to Leverage as a foundation for pursuing further opportunities with US state and federal law enforcement agencies and agencies internationally.

Share Performance

Stakk (ASX:SKK) shares are trading at AUD 0.029 on 29 September 2026, up 61.11% on the day — one of the largest percentage gains on the ASX on that date. The extraordinary move reflects the significance of the FBI contract disclosure, which validates ParaScript's technology at the highest level of US law enforcement credibility and suggests a meaningful near-term revenue contribution.

Sector Context

Signature and document verification is a critical function for law enforcement, financial institutions, healthcare providers, and government agencies. As AI-generated forgeries become more sophisticated, the need for trusted, high-accuracy verification technology grows. ParaScript's selection by the FBI — an agency with demanding accuracy and security standards — represents the strongest possible market endorsement of the technology's capabilities. The FBI use case establishes proof points that Stakk can leverage in sales conversations with other US federal and state agencies, as well as international law enforcement bodies. The broader market for signature verification spans trillions of dollars in transactions annually across banking, insurance, and government.

Risks and Uncertainty

The commercial terms and specific revenue contribution of the FBI contract are confidential, making it difficult for investors to precisely model its financial impact. The FY27 revenue target of $55 million+ is an expectation that has been raised from prior guidance — whether Stakk can achieve this depends on the timely execution of the FBI engagement, continued performance in its existing commercial segments, and successful conversion of additional opportunities in law enforcement and other sectors. Stakk must continue to demonstrate reliability and accuracy in the FBI deployment to support auto-renewal beyond December 2027.

Catalysts to Watch

The completion of Phase 2 of the FBI deployment — adding reference signature location capabilities — will be the next operational milestone. Any announcement of additional law enforcement agency contracts, in the US or internationally, would validate the law enforcement market expansion strategy. FY27 first-half revenue updates will be closely watched for evidence of the FBI contract's contribution. Achievement of the $55 million+ FY27 revenue target would be a significant financial milestone for Stakk and would likely drive further re-rating of the stock.

FAQs

Q: What does ParaScript do for the FBI?

A: ParaScript provides signature verification capabilities that support the FBI's assessment of physical signatures where authenticity or potential fraud is in question. Phase 1 (live verification capabilities) is fully deployed, and Phase 2 (capabilities to locate and prepare reference signatures for the verification process) is underway.

Q: How long does the FBI contract run?

A: The FBI engagement runs to December 2027 under the current agreement, with auto-renewal provisions for subsequent 12-month terms unless terminated by either party prior to a renewal date.

Q: What does the FBI contract mean for Stakk's revenue target?

A: The FBI engagement is expected to contribute meaningfully to Stakk's FY2027 revenue target, which has now been lifted to 'expected to surpass $55 million.' The exact revenue contribution is confidential, but management has signalled it is material to the FY27 outlook.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.